Total submissions: 21
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000148470 | SCV000051527 | benign | Arrhythmogenic right ventricular cardiomyopathy | 2013-06-24 | criteria provided, single submitter | research | |
Laboratory for Molecular Medicine, |
RCV000037307 | SCV000060964 | benign | not specified | 2017-10-11 | criteria provided, single submitter | clinical testing | p.Val158Gly in exon 5 of DSG2: This variant is not expected to have clinical sig nificance because it is not located within the splice consensus sequence and has been identified in 0.8% (212/25742) of Finnish chromosomes by the Genome Aggreg ation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs191143292). AC MG/AMP Criteria applied: BA1 (Richards 2015). |
Gene |
RCV000037307 | SCV000168233 | benign | not specified | 2012-05-01 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
CSER _CC_NCGL, |
RCV000211473 | SCV000212209 | likely benign | Arrhythmogenic right ventricular dysplasia 1 | 2015-03-11 | criteria provided, single submitter | research | |
Eurofins Ntd Llc |
RCV000037307 | SCV000231023 | likely benign | not specified | 2015-03-18 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001081252 | SCV000262068 | benign | Arrhythmogenic right ventricular dysplasia 10 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000250164 | SCV000318919 | benign | Cardiovascular phenotype | 2015-11-20 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000589551 | SCV000697889 | benign | not provided | 2016-01-26 | criteria provided, single submitter | clinical testing | Variant summary: This c.473T>G variant affects a conserved nucleotide, resulting in amino acid change from Val to Gly. 3/4 in-silico tools predict this variant to be damaging; however, results from in silico prediction are not definitive. This variant was found in 674/124228 control chromosomes including the broad and large populations from ExAC at a frequency of 0.0054255, which is more than 216 times greater than the maximal expected frequency of a pathogenic allele (0.000025) in this gene, suggesting this variant is benign. In addition, three homozygotes have also been reported from the European (Non-Finnish) population from ExAC, further supporting its benign outcome for the dominant disorders associated with this gene. This variant has been reported in literature in many patients with varying cardiological phenotypes, namely ARVD, DCM, Brugada Syndrome, and Arrhythmia; however, without strong evidence for causality. Rather, this variant was reported to co-occur with DSG2 R46Q and PKP2 p.L452X, supporting for a benign outcome. The variant has also been reported in an unaffected relative of an ARVD family, suggesting a lack of cosegregation (Syrris_2007). Multiple clinical labs have classified this variant as benign/likely benign. Taken together, this variant has been classified as Benign. |
ARUP Laboratories, |
RCV000589551 | SCV000883745 | benign | not provided | 2023-11-09 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000771099 | SCV000902737 | benign | Cardiomyopathy | 2018-04-09 | criteria provided, single submitter | clinical testing | |
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV000148470 | SCV000987331 | benign | Arrhythmogenic right ventricular cardiomyopathy | criteria provided, single submitter | clinical testing | ||
Center for Advanced Laboratory Medicine, |
RCV000852740 | SCV000995456 | benign | Primary dilated cardiomyopathy; Cardiomyopathy | 2019-06-11 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000589551 | SCV002498359 | likely benign | not provided | 2024-05-01 | criteria provided, single submitter | clinical testing | DSG2: BP4, BS2 |
Fulgent Genetics, |
RCV002490506 | SCV002796082 | likely benign | Arrhythmogenic right ventricular dysplasia 10; Dilated cardiomyopathy 1BB | 2022-04-22 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000148470 | SCV004819447 | benign | Arrhythmogenic right ventricular cardiomyopathy | 2024-02-05 | criteria provided, single submitter | clinical testing | |
CSER _CC_NCGL, |
RCV000148470 | SCV000190170 | likely benign | Arrhythmogenic right ventricular cardiomyopathy | 2014-06-01 | no assertion criteria provided | research | |
Diagnostic Laboratory, |
RCV000589551 | SCV001739838 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000037307 | SCV001923770 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000037307 | SCV001929204 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000037307 | SCV001953280 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000037307 | SCV001974892 | benign | not specified | no assertion criteria provided | clinical testing |